小分子药物在儿童神经瘤学
Stephanie Vairy1,2, George Michaiel3,4
1Division of Hematology-Oncology, Department of Pediatrics, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
精准医学使用小分子药物向儿童中枢神经系统 (CNS) 瘤的遗传变化. 进一步的临床试验对于将这些有前途的疗法整合到神经瘤治疗中至关重要.
科学领域:
- 儿童神经瘤学
- 分子诊断
- 精准医学
背景情况:
- 分子诊断技术为儿童中枢神经系统 (CNS) 瘤提供了先进的精准医学.
- 小分子药物针对中枢神经系统瘤的特定遗传和表观遗传变化.
- 本综述侧重于儿童神经瘤学的新兴小分子药物.
研究的目的:
- 为儿童中枢神经系统瘤提供小分子药物的概述.
- 突出作用机制,药理动力学,疗效和耐受性.
- 确定这些治疗方法的局限性和未来的研究需求.
主要方法:
- 正在研究或早期临床使用的小分子药物的审查.
- 专注于像ONC201,tazemetostat,vorasidenib,CDK抑制剂,selinexor和极光激酶A抑制剂这样的药物.
- 在儿童群体中分析临床前和早期临床数据.
主要成果:
- 几种小分子药物对儿童中枢神经系统瘤具有前景.
- 早期数据显示疗效,药动力学特征和耐受性各不相同.
- 限制包括研究异质性,缺乏大型儿科试验,以及中枢神经系统药物输送挑战.
结论:
- 小分子药物在儿童神经瘤学中是一个有前途的治疗途径.
- 强大的前性临床试验对于临床整合至关重要.
- 解决研究设计和药物供应方面的挑战对于推进医疗保健至关重要.
更多相关视频
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
相关概念视频
Factors Affecting Drug Response: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
